147 related articles for article (PubMed ID: 3707614)
21. Inhibition of microsomal metabolism and chemical oncogenesis in culture by naphthalene quinones.
Nesnow S; Bergman H; Garland H; Morris M
J Environ Pathol Toxicol; 1980 Nov; 4(5-6):17-30. PubMed ID: 7217845
[TBL] [Abstract][Full Text] [Related]
22. Hepatic aminopyrine N-demethylase system: interaction of aminopyrine with microsomal cytochrome P-450.
Hachino Y; Matsubara T; Hagihara B
Jpn J Pharmacol; 1981 Dec; 31(6):911-20. PubMed ID: 7334736
[TBL] [Abstract][Full Text] [Related]
23. Partial inhibition of hepatic microsomal aminopyrine N-demethylase by caffeine in partially purified cytochrome P450.
Govindwar SP; Kachole MS; Pawar SS
Biochim Biophys Acta; 1983 Mar; 756(2):191-5. PubMed ID: 6830852
[TBL] [Abstract][Full Text] [Related]
24. Interaction between antipyrine and aminopyrine.
Vesell ES; Passananti GT; Hepner GW
Clin Pharmacol Ther; 1976 Dec; 20(6):661-9. PubMed ID: 991537
[TBL] [Abstract][Full Text] [Related]
25. Effect of a single oral dose of methanol, ethanol and propan-2-ol on the hepatic microsomal metabolism of foreign compounds in the rat.
Powis G
Biochem J; 1975 May; 148(2):269-77. PubMed ID: 168885
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of microsomal drug metabolism by mitochondria and cytochrome c oxidation of extramitochondrial NADPH.
Tihanyi K; Mészáros K; Horváth I
Biochem Pharmacol; 1982 Mar; 31(5):661-3. PubMed ID: 6282273
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of phenelzine on oxidative microsomal enzyme systems of rat liver.
Bélanger PM; Atitsé-Gbeassor A
Can J Physiol Pharmacol; 1983 May; 61(5):524-9. PubMed ID: 6883204
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibody characterization of NADH- and NADPH-dependent hydroxylation of benzo(a)pyrene in liver microsomes from 5,6-benzoflavone-induced C57Bl/6 mice.
Brauze D; Mikstacka R; Pelkonen O
Acta Biochim Pol; 1990; 37(2):219-25. PubMed ID: 2072980
[TBL] [Abstract][Full Text] [Related]
29. The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A. Implications for drug-drug interactions and pharmacological activity of the main metabolite.
Fischer V; Rodríguez-Gascón A; Heitz F; Tynes R; Hauck C; Cohen D; Vickers AE
Drug Metab Dispos; 1998 Aug; 26(8):802-11. PubMed ID: 9698296
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of hepatic microsomal drug metabolism by the steroid hydroxylase inhibitor SU-10'603.
LaCagnin LB; Patricoski P; Colby HD
Biochem Pharmacol; 1988 Apr; 37(8):1625-8. PubMed ID: 3358792
[TBL] [Abstract][Full Text] [Related]
31. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes.
Pichard L; Fabre I; Fabre G; Domergue J; Saint Aubert B; Mourad G; Maurel P
Drug Metab Dispos; 1990; 18(5):595-606. PubMed ID: 1981707
[TBL] [Abstract][Full Text] [Related]
32. In vitro inhibitory action of cadmium on microsomal monooxygenases of rabbit lung.
Fukuhara M; Takabatake E
Biochem Pharmacol; 1982 Nov; 31(21):3425-9. PubMed ID: 6816246
[TBL] [Abstract][Full Text] [Related]
33. Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily.
Combalbert J; Fabre I; Fabre G; Dalet I; Derancourt J; Cano JP; Maurel P
Drug Metab Dispos; 1989; 17(2):197-207. PubMed ID: 2565211
[TBL] [Abstract][Full Text] [Related]
34. Examination of differences between benzo[a]pyrene and steroid hydroxylases in guinea pig adrenal microsomes.
Mochizuki H; Kominami S; Takemori S
Biochim Biophys Acta; 1988 Jan; 964(1):83-9. PubMed ID: 3334876
[TBL] [Abstract][Full Text] [Related]
35. Variations among untreated rabbits in benzo(a)pyrene metabolism and its modulation by 7,8-benzoflavone.
Raucy JL; Johnson EF
Mol Pharmacol; 1985 Feb; 27(2):296-301. PubMed ID: 3969073
[TBL] [Abstract][Full Text] [Related]
36. Inhibition by CO of hepatic benzo[a]pyrene hydroxylation and its reversal by monochromatic light.
Cooper DY; Schleyer H; Rosenthal O; Levin W; Lu AY; Kuntzman R; Conney AH
Eur J Biochem; 1977 Mar; 74(1):69-75. PubMed ID: 856576
[TBL] [Abstract][Full Text] [Related]
37. Effect of the suicide substrate 3,5-diethoxycarbonyl-2,6-dimethyl-4-ethyl-1,4-dihydropyridine on the metabolism of xenobiotics and on cytochrome P-450 apoproteins.
Tephly TR; Black KA; Green MD; Coffman BL; Dannan GA; Guengerich FP
Mol Pharmacol; 1986 Jan; 29(1):81-7. PubMed ID: 3080674
[TBL] [Abstract][Full Text] [Related]
38. Ellipticines and human liver microsomes: spectral interaction with cytochrome P-450 and hydroxylation. Inhibition of aryl hydrocarbon metabolism and mutagenicity.
Lesca P; Beaune P; Monsarrat B
Chem Biol Interact; 1981 Sep; 36(3):299-309. PubMed ID: 7285236
[TBL] [Abstract][Full Text] [Related]
39. Inhibition and induction of hepatic drug metabolism in rats and mice by nafimidone and its major metabolite nafimidone alcohol.
Rush WR; Smith SA; Mulvey JH; Graham DJ; Chaplin MD
Drug Metab Dispos; 1987; 15(4):571-8. PubMed ID: 2888633
[TBL] [Abstract][Full Text] [Related]
40. Dimethylaminoethyl 2,2-diphenylvalerate HCl (SKF 525-A)--in vivo and in vitro effects of metabolism by rat liver microsomes--formation of an oxygenated complex.
Schenkman JB; Wilson BJ; Cinti DL
Biochem Pharmacol; 1972 Sep; 21(17):2373-83. PubMed ID: 4647071
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
